The government's policy of screening long staying foreigners for AIDS is an attempt to find a scapegoat for a national health problem

FIVE-DAY-OLD Andrew Gobea became the first newborn to undergo gene therapy when surgeons at a Los Angeles hospital injected him recently with gene-altered cells obtained from his mother's placental

AIDS victims the world over are dismayed by the discovery that taking azidothymidine as soon as HIV infection is confirmed does not delay death any further than if they took it after symptoms develop.

Scientists claim a new mode of administering drugs would strip the main AIDS drug Azidothymidine AZT of its side effects.

VARIOUS studies indicate that the risk of contracting AIDS during receiving or providing dental treatment is negligible because in the past decade worldwide, only 5 patients -- and all from a

After generating a lot of scientific interest worldwide, neem is now attracting pesticide manufacturers and pharmaceuticals keen to exploit its various properties.

Neem provides a cheap and harmless mosquito repellent that is effective against the malaria carrying Anopheles species, which is becoming increasingly resistant to pesticides.

Scientists believe neem stimulates the body's immune system and are working on the possibility of using it in treating AIDS.

A TIENTS who do not respond to AZT -the primary AIDS therapeutic drug produced and patented almo worldwide by Burroughs Wellcome Co -now have hope. Studies at the US Nationi Institutes of

Hiroshi Nakajima's re election as WHO's director general is being challenged on grounds of high handedness.

Pages